In a nutshell This study investigated if vitamin D levels and disease activity are linked in juvenile idiopathic arthritis (JIA). They found that low vitamin D levels were associated with higher disease activity. Some background Juvenile idiopathic arthritis (JIA) is caused by inflammation in the joints. The cause of JIA is unknown. In JIA, the...
Read MoreRheumatoid Arthritis Posts on Medivizor
What is the best strategy to achieve remission in juvenile idiopathic arthritis?
In a nutshell This study investigated three treatment strategies to achieve remission in patients with juvenile idiopathic arthritis (JIA). They found that all treatment strategies were effective in achieving remission in JIA. Some background Juvenile idiopathic arthritis (JIA) is caused by inflammation. It causes painful swelling in the joints...
Read MoreIntensive treatment – is this the most effective approach to achieving remission in rheumatoid arthritis?
In a nutshell This study investigated intensive treatment to achieve remission in rheumatoid arthritis (RA). They found that intensive treatment was effective at achieving remission. Some background Rheumatoid arthritis (RA) is a long-term condition. It is caused by painful inflammation in the joints. To treat RA, patients are prescribed drugs...
Read MoreIs it possible to maintain low disease activity in rheumatoid arthritis with low dose baricitinib?
In a nutshell This study investigated if reducing the dose of baricitinib (BCB; Olumiant) maintained low disease activity (LDA) in rheumatoid arthritis (RA). They found that a lower dose of BCB maintained LDA in some patients while the others could be rescued by switching to the original dose. Some background Rheumatoid...
Read MoreDoes emotional health impact pain in rheumatoid arthritis?
In a nutshell This study investigated if emotional health affects pain in patients with rheumatoid arthritis (RA). They found that emotional health, along with physical state can have an effect on pain in RA. Some background Rheumatoid arthritis (RA) is a long-term condition. It leads to painful swelling and inflammation in the joints. As...
Read MoreTofacitinib for the treatment of rheumatoid arthritis: evidence from real-world clinical practice
In a nutshell This study reviewed information on the use of tofacitinib (Xeljanz) for the treatment of rheumatoid arthritis (RA). They found that tofacitinib is effective and well-tolerated for patients with RA. Some background Tofacitinib (TFB) is a new drug to treat rheumatoid arthritis (RA). It blocks a type of enzyme...
Read MoreDoes tocilizumab increase cardiovascular risk in patients with rheumatoid arthritis?
In a nutshell This study investigated if tocilizumab (TCZ; Actemra) increases cardiovascular (CVD) risk in patients with rheumatoid arthritis (RA). They found that CVD risk associated with TCZ was similar to other biological drugs. Some background Rheumatoid arthritis (RA) is caused by excessive inflammation. Inflammation leads to pain and...
Read MoreExercise and anti-TNF medication – can this combination improve cardiovascular health in patients with rheumatoid arthritis?
In a nutshell This study investigated if exercise and anti-TNF medication can improve cardiovascular health (CVH) in patients with rheumatoid arthritis (RA). They found that combining exercise and anti-TNF medication improved CVH in these patients. Some background Rheumatoid arthritis (RA) is a long-term condition caused by inflammation in the joints....
Read MoreEtanercept and Abatacept: is there a risk of heart failure in patients with rheumatoid arthritis?
In a nutshell This study investigated the risk of heart failure in patients treated with either etanercept (Enbrel) or abatacept (Orencia) for rheumatoid arthritis (RA). They found that these drugs do not increase the risk of heart failure. Some background Rheumatoid arthritis (RA) is caused by chronic inflammation. This causes pain and swelling...
Read MoreIs baricitinib a safe treatment for rheumatoid arthritis?
In a nutshell This study investigated the safety of baricitinib (Olumiant) for the treatment of rheumatoid arthritis (RA). They found that baricitinib was well tolerated in patients with moderate-severe RA. Some background Rheumatoid arthritis (RA) is treated with medications to reduce inflammation. In RA, inflammation causes painful swelling and...
Read MoreManaging flare-ups in rheumatoid arthritis: can etanercept improve disease symptoms?
In a nutshell This study investigated if etanercept is effective at treating flare-ups in patients with rheumatoid arthritis. They found that etanercept reduces disease activity following flare-ups in these patients. Some background Rheumatoid arthritis (RA) is a long-term condition caused by inflammation. In RA, inflammation causes the damage to...
Read MoreDoes poor diet increase inflammation in rheumatoid arthritis?
In a nutshell This study investigated if diet quality was associated with disease activity in patients with rheumatoid arthritis. They found that patients with poor diet had higher levels of inflammation. Some background Rheumatoid arthritis (RA) is a chronic (long-term) condition. It is an auto-immune disease. In RA, the immune system attacks...
Read More
